Skip to content
akaturk Academic measurement
2025 SJR Q2 OA 1 matched articles

Journal detail

Exploration of Targeted Anti-tumor Therapy

Publisher
Open Exploration Publishing Inc
Country
China · Asiatic Region
Type
journal
ISSN
  • 26923114
Scopus 0,883 SJR
Scopus Q2 SJR Q
WoS JCR Q
WoS JIF
Scopus 21 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,883
  • Quartile Q2
  • H-Index 21
  • Cites/doc 3,77
  • Docs (3y) 215
  • Cites (3y) 827

Clarivate

Web of Science · JCR

No JCR match

Subject classification

Categories (SJR)

  • Cancer Research Q3
  • Oncology Q2

Areas

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q2 0,883 21
2024 Q3 0,677 15
2023 Q2 0,692 15
2022 15
2021 15
2020 15